Motexafin gadolinium (MGd) is a unique therapeutic agent that localizes in
cancer cells and increases tumor response to ionizing radiation and certain
chemotherapeutics. The in vitro intracellular localization, accumulation,
and retention of MGd in murine EMT6 mammary sarcoma and Rif-1 fibrosarcoma
cell lines were studied using interferometric Fourier fluorescence microsco
py. MGd cellular uptake was semiquantified using its characteristic fluores
cence emission band centered at 758 nm. Colocalization studies were perform
ed using mitochondrial, endoplasmic reticulum, Golgi apparatus, nuclear, an
d lysosomal fluorescent organelle probes, and verified using interferometri
c Fourier spectroscopy. Cellular uptake was gradual and increased significa
ntly with incubation time. MGd localized primarily within the lysosomes and
endoplasmic reticulum, and to a lesser extent within the Golgi apparatus a
nd mitochondria. Mitochondrial staining was increased in media without seru
m. No nuclear uptake was detected in the Rif-1 cells, but after 48 h nuclea
r uptake was observed in 15% of EMT6 cells. These results indicated that MG
d accumulates within cytoplasmic compartments. The sustained intracellular
localization of MGd may, in part, account for its unique radiation and chem
otherapy enhancement properties. Interferometric Fourier fluorescence micro
scopy is a potentially powerful tool in delineating and verifying localizat
ion sites of therapeutic agents.